The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Robert L. Frye; Malcolm R. Bell; Hartzell V. Schaff; Richard Holubkov; Katherine M. Detre

doi:10.1007/s11892-002-0052-z

The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Robert L. Frye, Malcolm R. Bell, Hartzell V. Schaff, Richard Holubkov, Katherine M. Detre

Cardiovascular Surgery

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

The role of percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) in patients with diabetes mellitus (DM) is evolving. Data from clinical trials and observational studies are reviewed as well as current clinical practice guidelines. The importance of aggressive medical therapy to achieve recommended glycemic control targets, and management of usual risk factors in patients with coronary artery disease (CAD) cannot be overemphasized regardless of the revascularization therapy selected. Patients with type 2 diabetes are at increased risk for CAD, which is the cause of death in the majority of patients. Outcomes following PCI and CABG are worse in patients with DM compared to those without DM. This calls for randomized trials and other studies focused on patients with DM.

Original language	English (US)
Pages (from-to)	16-20
Number of pages	5
Journal	Current diabetes reports
Volume	2
Issue number	1
DOIs	https://doi.org/10.1007/s11892-002-0052-z
State	Published - Feb 2002

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.1007/s11892-002-0052-z

Cite this

@article{a37e4b74d22a420e885f5626fb2d6fdb,

title = "The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.",

abstract = "The role of percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) in patients with diabetes mellitus (DM) is evolving. Data from clinical trials and observational studies are reviewed as well as current clinical practice guidelines. The importance of aggressive medical therapy to achieve recommended glycemic control targets, and management of usual risk factors in patients with coronary artery disease (CAD) cannot be overemphasized regardless of the revascularization therapy selected. Patients with type 2 diabetes are at increased risk for CAD, which is the cause of death in the majority of patients. Outcomes following PCI and CABG are worse in patients with DM compared to those without DM. This calls for randomized trials and other studies focused on patients with DM.",

author = "Frye, {Robert L.} and Bell, {Malcolm R.} and Schaff, {Hartzell V.} and Richard Holubkov and Detre, {Katherine M.}",

year = "2002",

month = feb,

doi = "10.1007/s11892-002-0052-z",

language = "English (US)",

volume = "2",

pages = "16--20",

journal = "Current diabetes reports",

issn = "1534-4827",

publisher = "Current Medicine Group",

number = "1",

}

TY - JOUR

T1 - The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

AU - Frye, Robert L.

AU - Bell, Malcolm R.

AU - Schaff, Hartzell V.

AU - Holubkov, Richard

AU - Detre, Katherine M.

PY - 2002/2

Y1 - 2002/2

N2 - The role of percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) in patients with diabetes mellitus (DM) is evolving. Data from clinical trials and observational studies are reviewed as well as current clinical practice guidelines. The importance of aggressive medical therapy to achieve recommended glycemic control targets, and management of usual risk factors in patients with coronary artery disease (CAD) cannot be overemphasized regardless of the revascularization therapy selected. Patients with type 2 diabetes are at increased risk for CAD, which is the cause of death in the majority of patients. Outcomes following PCI and CABG are worse in patients with DM compared to those without DM. This calls for randomized trials and other studies focused on patients with DM.

AB - The role of percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) in patients with diabetes mellitus (DM) is evolving. Data from clinical trials and observational studies are reviewed as well as current clinical practice guidelines. The importance of aggressive medical therapy to achieve recommended glycemic control targets, and management of usual risk factors in patients with coronary artery disease (CAD) cannot be overemphasized regardless of the revascularization therapy selected. Patients with type 2 diabetes are at increased risk for CAD, which is the cause of death in the majority of patients. Outcomes following PCI and CABG are worse in patients with DM compared to those without DM. This calls for randomized trials and other studies focused on patients with DM.

UR - http://www.scopus.com/inward/record.url?scp=3142748908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142748908&partnerID=8YFLogxK

U2 - 10.1007/s11892-002-0052-z

DO - 10.1007/s11892-002-0052-z

M3 - Review article

C2 - 12643118

AN - SCOPUS:3142748908

SN - 1534-4827

VL - 2

SP - 16

EP - 20

JO - Current diabetes reports

JF - Current diabetes reports

IS - 1

ER -

The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this